LITE STRATEGY INC (LITS) Fundamental Analysis & Valuation
NASDAQ:LITS • US55279B3015
Current stock price
1.18 USD
0 (0%)
At close:
1.21 USD
+0.03 (+2.54%)
After Hours:
This LITS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. LITS Profitability Analysis
1.1 Basic Checks
- In the past year LITS has reported negative net income.
- LITS had a negative operating cash flow in the past year.
- In the past 5 years LITS reported 4 times negative net income.
- In the past 5 years LITS always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of LITS (-87.20%) is worse than 72.29% of its industry peers.
- LITS's Return On Equity of -94.18% is in line compared to the rest of the industry. LITS outperforms 45.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -87.2% | ||
| ROE | -94.18% | ||
| ROIC | N/A |
ROA(3y)-23.53%
ROA(5y)-24.99%
ROE(3y)-56.59%
ROE(5y)-71.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for LITS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. LITS Health Analysis
2.1 Basic Checks
- LITS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for LITS remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, LITS has more shares outstanding
- There is no outstanding debt for LITS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- LITS has an Altman-Z score of -13.97. This is a bad value and indicates that LITS is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of LITS (-13.97) is worse than 79.65% of its industry peers.
- There is no outstanding debt for LITS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -13.97 |
ROIC/WACCN/A
WACC9.13%
2.3 Liquidity
- LITS has a Current Ratio of 13.50. This indicates that LITS is financially healthy and has no problem in meeting its short term obligations.
- LITS has a better Current ratio (13.50) than 88.95% of its industry peers.
- LITS has a Quick Ratio of 13.50. This indicates that LITS is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Quick ratio value of 13.50, LITS belongs to the best of the industry, outperforming 88.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.5 | ||
| Quick Ratio | 13.5 |
3. LITS Growth Analysis
3.1 Past
- LITS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -189.72%.
- Looking at the last year, LITS shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)-189.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.4%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, LITS will show a very strong growth in Earnings Per Share. The EPS will grow by 32.35% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y40.92%
EPS Next 2Y32.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. LITS Valuation Analysis
4.1 Price/Earnings Ratio
- LITS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year LITS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as LITS's earnings are expected to grow with 32.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.35%
EPS Next 3YN/A
5. LITS Dividend Analysis
5.1 Amount
- No dividends for LITS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LITS Fundamentals: All Metrics, Ratios and Statistics
1.18
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10 2026-02-10
Earnings (Next)05-11 2026-05-11
Inst Owners22.75%
Inst Owner Change0%
Ins Owners10.92%
Ins Owner Change-16.12%
Market Cap42.90M
Revenue(TTM)N/A
Net Income(TTM)-15.95M
Analysts43.33
Price TargetN/A
Short Float %0.29%
Short Ratio0.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.53 | ||
| P/tB | 2.53 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.39
EYN/A
EPS(NY)-3.78
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS0
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -87.2% | ||
| ROE | -94.18% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-23.53%
ROA(5y)-24.99%
ROE(3y)-56.59%
ROE(5y)-71.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 0% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 13.5 | ||
| Quick Ratio | 13.5 | ||
| Altman-Z | -13.97 |
F-Score2
WACC9.13%
ROIC/WACCN/A
Cap/Depr(3y)4.03%
Cap/Depr(5y)80.47%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-189.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.4%
EPS Next Y40.92%
EPS Next 2Y32.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-168.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.7%
OCF growth 3YN/A
OCF growth 5YN/A
LITE STRATEGY INC / LITS Fundamental Analysis FAQ
What is the ChartMill fundamental rating of LITE STRATEGY INC (LITS) stock?
ChartMill assigns a fundamental rating of 2 / 10 to LITS.
What is the valuation status of LITE STRATEGY INC (LITS) stock?
ChartMill assigns a valuation rating of 1 / 10 to LITE STRATEGY INC (LITS). This can be considered as Overvalued.
What is the profitability of LITS stock?
LITE STRATEGY INC (LITS) has a profitability rating of 0 / 10.
What is the financial health of LITE STRATEGY INC (LITS) stock?
The financial health rating of LITE STRATEGY INC (LITS) is 7 / 10.